INCIDENCE OF TREATMENT-ASSOCIATED IMAGING CHANGES IN NEWLY DIAGNOSED MGMT PROMOTER-METHYLATED GLIOBLASTOMA TREATED WITH CILENGITIDE (EORTC 26071-CENTRIC STUDY): INTERIM ANALYSIS

C. M. Flies; M. Friedrich; P. Lohmann; K. van Garderen; M. Smits; J. C. Tonn; M. Weller; N. Galldiks; T. J. Snijders

doi:10.1093/neuonc/noac174.327

INCIDENCE OF TREATMENT-ASSOCIATED IMAGING CHANGES IN NEWLY DIAGNOSED MGMT PROMOTER-METHYLATED GLIOBLASTOMA TREATED WITH CILENGITIDE (EORTC 26071-CENTRIC STUDY): INTERIM ANALYSIS

C. M. Flies, M. Friedrich, P. Lohmann, K. van Garderen, M. Smits, J. C. Tonn, M. Weller, N. Galldiks, T. J. Snijders

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	ii93
Journal	Neuro-oncology
Volume	24
DOIs	https://doi.org/10.1093/neuonc/noac174.327
Publication status	Published - 5 Sept 2022

Access to Document

10.1093/neuonc/noac174.327

Cite this

Flies, C. M., Friedrich, M., Lohmann, P., van Garderen, K., Smits, M., Tonn, J. C., Weller, M., Galldiks, N., & Snijders, T. J. (2022). INCIDENCE OF TREATMENT-ASSOCIATED IMAGING CHANGES IN NEWLY DIAGNOSED MGMT PROMOTER-METHYLATED GLIOBLASTOMA TREATED WITH CILENGITIDE (EORTC 26071-CENTRIC STUDY): INTERIM ANALYSIS. Neuro-oncology, 24, ii93. https://doi.org/10.1093/neuonc/noac174.327

@article{1ed07cd96d3544a493248c3e1ff899d7,

title = "INCIDENCE OF TREATMENT-ASSOCIATED IMAGING CHANGES IN NEWLY DIAGNOSED MGMT PROMOTER-METHYLATED GLIOBLASTOMA TREATED WITH CILENGITIDE (EORTC 26071-CENTRIC STUDY): INTERIM ANALYSIS",

author = "Flies, {C. M.} and M. Friedrich and P. Lohmann and {van Garderen}, K. and M. Smits and Tonn, {J. C.} and M. Weller and N. Galldiks and Snijders, {T. J.}",

year = "2022",

month = sep,

day = "5",

doi = "10.1093/neuonc/noac174.327",

language = "English",

volume = "24",

pages = "ii93",

journal = "Neuro-oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

}

Flies, CM, Friedrich, M, Lohmann, P, van Garderen, K, Smits, M, Tonn, JC, Weller, M, Galldiks, N & Snijders, TJ 2022, 'INCIDENCE OF TREATMENT-ASSOCIATED IMAGING CHANGES IN NEWLY DIAGNOSED MGMT PROMOTER-METHYLATED GLIOBLASTOMA TREATED WITH CILENGITIDE (EORTC 26071-CENTRIC STUDY): INTERIM ANALYSIS', Neuro-oncology, vol. 24, pp. ii93. https://doi.org/10.1093/neuonc/noac174.327

TY - JOUR

T1 - INCIDENCE OF TREATMENT-ASSOCIATED IMAGING CHANGES IN NEWLY DIAGNOSED MGMT PROMOTER-METHYLATED GLIOBLASTOMA TREATED WITH CILENGITIDE (EORTC 26071-CENTRIC STUDY): INTERIM ANALYSIS

AU - Flies, C. M.

AU - Friedrich, M.

AU - Lohmann, P.

AU - van Garderen, K.

AU - Smits, M.

AU - Tonn, J. C.

AU - Weller, M.

AU - Galldiks, N.

AU - Snijders, T. J.

PY - 2022/9/5

Y1 - 2022/9/5

U2 - 10.1093/neuonc/noac174.327

DO - 10.1093/neuonc/noac174.327

M3 - Meeting Abstract

SN - 1522-8517

VL - 24

SP - ii93

JO - Neuro-oncology

JF - Neuro-oncology

ER -